Legal & General Group
AMPE

Legal & General Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Legal & General Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-51
Closed -$3K – 3518
2022
Q2 		$3K Sell
51
-16
-24% -$1.19K ﹤0.01% 3483
2022
Q1 		$9K Hold
67
– – ﹤0.01% 3442
2021
Q4 		$11K Hold
67
– – ﹤0.01% 3455
2021
Q3 		$33K Hold
67
– – ﹤0.01% 3097
2021
Q2 		$34K Buy
+67
New +$36K ﹤0.01% 3096
2019
Q3 		– Sell
-39
Closed -$5K – 3450
2019
Q2 		$5K Hold
39
– – ﹤0.01% 3452
2019
Q1 		$7K Hold
39
– – ﹤0.01% 3293
2018
Q4 		$5K Hold
39
– – ﹤0.01% 3342
2018
Q3 		$6K Hold
39
– – ﹤0.01% 3360
2018
Q2 		$26K Buy
+39
New +$29.2K ﹤0.01% 3086
2017
Q3 		– Sell
-1,087
Closed -$170K – 3332
2017
Q2 		$170K Buy
1,087
+1,070
+6,294% +$216K ﹤0.01% 2362
2017
Q1 		$4K Hold
17
– – ﹤0.01% 3250
2016
Q4 		$5K Buy
+17
New +$4.05K ﹤0.01% 3276
2015
Q2 		– Sell
-27
Closed -$60K – 2791
2015
Q1 		$60K Hold
27
– – ﹤0.01% 2401
2014
Q4 		$27K Hold
27
– – ﹤0.01% 2608
2014
Q3 		$29K Buy
+27
New +$45.5K ﹤0.01% 2583

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Legal & General Group's AMPE Position: Q3 2022 in Review

Legal & General Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 51 shares — an estimated $3K sold.

Legal & General Group first reported a position in AMPE in Q3 2014 and held it in 16 quarters. The position peaked at $170K in Q2 2017. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • Legal & General Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 51 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $3K.
  • Legal & General Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2014 and held it in 16 quarters.
  • Legal & General Group's Ampio Pharmaceuticals Inc. position peaked at $170K in Q2 2017.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.